Equity Overview
Price & Market Data
Price: $0.22
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $4,317,808
Volume: 0
Performance Metrics
1 Week: -34.72%
1 Month: -78.00%
3 Months: -78.00%
6 Months: -4.35%
1 Year: -86.59%
YTD: -51.11%
Details
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.